E3A Healthcare is transforming women’s health by addressing one of the greatest gaps in medical innovation. We develop first-in-class medical devices and AI-powered solutions that make critical healthcare services more accessible, reliable, and impactful for women and families worldwide.
Founded in 2019 at the National University of Singapore (NUS), our expertise in bio-signal processing and biosensors has allowed us to serve over 250,000 families globally and save hundreds of newborns. Backed by world-class investors like Enterprise Singapore, Hong Kong X Fund, and the National University of Singapore, we are building a future where women’s health innovation is at the forefront of global progress.
Our Solutions
E3A develops first-in-class medical devices and AI-Powered health solutions designed to address the most pressing, unmet needs in women’s health
Our Partners
Our Investors and Sponsors
Contact Us
We're eager to hear from you! Get in touch with us and let's explore how we can join hands to deliver better care for families worldwide.